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tively high amounts for further structural characteriza- 
tion as well as elucidation of the molecular basis for 
their antifungal activity. 
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The detailed mechanism of a&on of androgens remains unknown. We have used an androgen-dependent human prostate cancer cell line and a 
subtractive cDNA hybridisation strategy to enrich for androgen-dependent sequences. This yielded a cDNA clone which exhibits the characteristics 
of a primary trans-activated target for androgens. This androgen-regulated gene encodes a polyadenylated 4.5 kb mRNA which is induced 
30-50-fold within 3 h of treatment with 10 nM dihydrotestosterone. The induction does not require continued protein synthesis as it is maintained 
in the presence of protein synthesis inhibitors. 
Androgen-induced; Dihydrotestostcrone; mRNA; Gene 
1. INTRODWCTIQN 
The molecular mechanisms of androgen action re- 
main poorly understood despite considerable attention. 
The receptor for androgens has .been cloned and se- 
quenced [ 1] and &own to belong to the steroid/thyroid/ 
retinoid superfamily of transcriptional activators [2], 
although no primary gene targets for androgen action 
have yet been identified. Some androgen responsive 
gents have been identified, but the long time courses of 
induction suggests that these genes are not primary tar- 
gets for androgen action but are cis-regulated by the 
products of early genes [3,4]. In at least one system, 
liganded androgen receptor is capable of acting as a 
transcriptional activator through a permissive nucleo- 
tide response element in the long terminal section of the 
mouse mammary tumour virus genome. This response 
element is also activated by liganded glucocorticoid and 
progesterone receptors [5,6], thus throwing doubt on 
the existence of a unique response element for the ligan- 
ded androgen receptor. 
have isolated the cDNA for a gene which has all the 
properties of a primary response gene for androgens; its 
mRNA is induced within 3 h of treatment with physio- 
logical concentrations of DI-IT and its induction is not 
abolished by co-treatment with cycloheximide or puro- 
mycin. The induction is abolished by treatment with 
actinomycin D. The specificity of the induction of this 
mRNA is demonstrated by the lack of effect of pro- 
gesterone or dexamethasone, indicating a unique 
response element for androgens in the 5’ flanking region 
of this gene. 
2. MATERIALS AND METHODS 
Androgen-dependent LNCaP cells were routinely maintained in 
RPM1 1640 medium (Flow Laboratories. UK) supplemented with 
10% foctal calf serum (FCS), 2 mM L-glutaminc and IO nM DHT at 
37°C in 95% air/S% CO,. Cells were free from niycoplasma contami- 
nation. Total cellular RNA was extracted by the guanidiurn isothio- 
cyanate method, with the sclcction of mRNA by polyHA+ chromato- 
graphy on oligo-dT ccllulosc columns. 
The LNCaP human prostate cancer cell line is de- 
pendent upon androgens for continued growth [7], 
Withdrawal of all androgens from these cells causes a 
complete cessation of cell growth within 3 days. We 
have used these cells in a subtractice cDNA hybridisa- 
tion system [S] to enrich for sequences that are rapidly 
induced by dihydrotestostcrone (DHT) in an attempt to 
isolate genes which fulfil the requirements for trmts- 
activated androgen targets. Using this technique WC 
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mRNA was isolated by 2 rounds ofoligo-dl’chromatography from 
LNCdP cells that had been treated for 12 h with 10 nM DIGIT in 
ethanol vchiclc such that the ethanol concentration rcmaincd at 0. I% 
v/v. Comrol cells rcccivcd ethanol vchiclc alone. Prior to this 12 h 
trcauncnt the cells wcrc withdrawn from all androgcnic growth stimuli 
by culturing the cells for 7 days in RPM1 1640 supplemcntcd with 10% 
dcxtran-coated charcoal-stripped FCS (DCC-FCS) [9]. 10 pg of the 
mRNA from LNCaPcells tre;ltcd for 12 h with IOnM DHT (+Acells) 
was tlicn used to synthcsisc single stranded cDNA. weakly Iabcllcd by 
the incorporation of [‘:P]dCTP (Amcrshiun) [IO]. Following purifica- 
tion by spun-column chromatography on Scphacl~x G-50 (Pharma. 
cia), this cDNA was hybrid&d IO ti IO-fold mass cxccss 01’ mRNA 
from control LNCaP cells (-A cells) at GX”C r’or 22 h [I I], Following 
the hybridisatiorl, single rtrandcd cDNA was rcmovcd from 
cDNA:mRNA hctcroduplcxcs by hydrosvlaputitc chronralograpby 
(I 2). and after mRNA alkalitlc hydrolysis b..~i puriticatiorr, the cDNA 
was rc-hybrid&d lo another 1 O-fold mass cxccss of mRNA rrotu -,A 
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cells. again at 6S°C for 22 h. Following another round of hydroxyla- 
patite chromatography the subtracted sDNA was purified by Sepha- 
dsx G-SO spin columns, labelled to high specific activity with 
[“P]dCTP by the Klenow fragment/random primer method [I 31 and 
used to probe 100000 plaques of a +A directional cDNA library 
constructed in Lambda ZAP (Stratagene). Duplicate nylon filter lifts 
(Hybond-N, Amcrsham) were hybridised overnight at 42°C in 0.05 M 
Tris. pH 7.5, containing SO%, v/v formamide, 0.2% w/v polyvinylpyr- 
rolidone. 0.2% w/v Ficoll, 1 M NaCl. 0.1% w/v sodium pyrophos- 
phate, 10% w/v dextran sulphate, 1% w/v SDS, and 50 &II-II dena- 
tured salmon sperm DNA. The Alters were then washed in 0.2 x SSC 
(SSC is 0.15 M NaCl, 0.015 M sodium citrate, pH 7.5) with 0.1% w/v 
SDS at 55°C for I h and exposed to X-ray film overnight at -70°C 
with intensifying screens. A single, strongly hybridising plaque was 
identified. picked and rescreened using the same subtracted probe. 
Positives from the secondary screening were plaque-purified and in 
vivo subcloned into the pl3luescript plasmid [14]. From this plasmid 
was isolated a 1 .I kb cDNA insert which was purified by low-melting- 
point agarose electrophoresis and used in the subsequent Northern 
Fig. 2. Northern analysis of IO pg aliquots of mRNA showing the 
effect of protein or RNA synthesis inhibitors on the expressioa of au 
androgen-induced gene. Lane 1, control cells withdrawn from hndro_ 
gens for a 7 day period. Lane 2, cells withdrawn from androgbns for 
7 days and then treated with 10 nM DHT for 12 h. Lane 5, cells 
withdrawn from androgens for 7 days and then treated with 10 nM 
DHT and 1 p&/ml cycloheximide for 12 h. Lane 4, cells With&awn 
from androgens for 7 days and then treated with IO nM DHT bnd 50 
PgIrnl puromycin for 12 h. Lane 5, cells withdrawn from androgens 
for 7 days and then treated with IO nM DHT and 2,U&ml actingmycin 
D for 12 h. 
analyses. 
For Northern blots, IO fig aliquots of mRNA, derived from LNCaP 
cells ur,der different experimental conditions and purified by 2 rounds 
of poly-A+ chromatography, were fractionated through I % denatu- 
ring formaldehyde agarose gels and transferred to Hybond-N. Hybri- 
disation conditions for the Northern blots were as above for the 
plaque screening, using random primer-labelled insert cDNA. Filters 
were washed at 55°C in 0.2 x SSC with 0.1% w/v SDS for 1 h and 
exposed to X-ray film at -70°C with intensifying screens for 48 h. 
Following exposure. the blots were stripped and rehybridised to a 
p-actin cDNA. 
3. RESULTS AND DISCUSSION 
The suitability of the LNCaP cell line as an in vitro 
model for androgen dependence is illustrated in Fig. 1. 
After the withdrawal of all androgens by culturing the 
cells in medium containing DCC-FCS the cells stop 
dividing and remain in stationary phase over the 9 days 
v) 
% 
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Fig. I. Time course ofthc rcspor~se of LNCaP human prostate cancer 
cells to IO nM DW. Cells were scedcd (10’ cells per 25 cm’ flask) in 
routine maintcnancc medium titld :IIIOWCLI to attach f<)r 24 h. This 
medium was then retnovcd and replaced with rncdium containing 10% 
LXX-PCSand the cells culturrd for it further 7 days. The tncdium was 
chtmgcd 3 timcs during this period. After the 7 day withdrawal period. 
cithcr IO nM DHT (X--X) or ethanol vchiclc (.I,--.;) wcrc added to the 
cells and the cxpcrimcnt continued for 9 ditys with medium and drug 
chnngcs cwy 4% II. Quadrrtplicatc flasks afalls wcrc trypsiniscd and 
~khilit~cou~~tcd in +I hacnwcytamctcr ttftcrstaining with Trypan blue. 
‘rhc datil ptwetttcd arc tlrc IIIC;~IX CSD. 
of the growth experiments. However, the cells that are 
treated with 10 nM DHT recover, after a lag phase of 
2-3 days, and grow thereafter with a doubling tibe of 
approximately 4 days, These cells wil continue to divide 
at this rate for as long as IO nM DHT is provided. 
The Northern blot illustrated in Fig. 2 clearly shows 
the induction of the early androgen-dependent gene 
over a 12 h period in the LNCaP cells treated with 10 
nM DHT alone or 10 nM DHT with the protein synthe- 
sis inhibitors cycloheximide and puromycin. This de- 
monstrates that protein synthesis is not required for the 
DHT-associated increase in this transcript, implying 
that this induction is a primary response to the addition 
of physiological concentrations of DIGIT and doe’s not 
require prior induction of gene expression at either the 
transcriptional or translational level. The induced 
mI2NA is not a single band but a doublet with the 
upper, major band running at approximately 4.5 kb and 
the fainter, lower band running at approximatel) 4.4 
kb. Scanning densitometry revealed that the fold iriduc- 
tion of this transcript is between 30- and 50-fold over 
the untreated control cells. The induction is aboljshed 
by the addition of the RNA synthesis inhibitor aotino- 
mycin D. 
The time course of the induction, illustrated in Fig. 
3, demonstrates that this is indeed an early transcriptio- 
nal response of these cells to androgens, The trans,cripl 
appears to be fully induced within 6 h of treatment with 
10 nM DHT and does not increase in magnitude with 
longer exposure to the hormone, indicating full Qccu- 
panty of the 5’ hormone response element by the Ilgan- 
ded androgen receptor within that time. 
The usefulness of this clone for studying the mojecu- 
lar mechanisms of androgen action is confirmed bi the 
data in Fig. 4. This Northern blot shows that the itldue- 
tion of the 4.5 kb transcript is unique to DIGIT and ib not 
seen upon treatment of the cells with either 10 nM pro- 
133 
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Fig. 3. Northern analyis of 10~6 aliquots of mRNA showing the time 
course of induction of the androgen-induced gene. Lane 1, control 
aodrogen withdrawn cells. Lane 2, androgen withdrawn cells treated 
with 10 nM DHT for 3 h. Lane 3, androgen withdrawn cells treated 
with 10 nM DHT for 6 h. Lane 4, androgcn withdrawn cells treated 
with 10 nM DNT for 12 h. 
gesterone or 10 nM dexamethasone. These data suggest 
that this induction is not due to a mouse mammary 
tumour virus-related hormone response lement but to 
a discrete androgen response lement. 
The current model of action of members of the ste- 
roid/thyroid/retinoid superfamily proposes the very 
early regulation of one or a small number of transcrip- 
tionally activated genes. The expression of these in turn 
regulates the expression of later genes in a cell and/or 
tissue specific manner, leading ta cell growth or diffe- 
rentiation [lS]. Supporting evidence for this model has 
recently been provided by the cloning of an early reti- 
noic acid-regulated gene in F9 murine teratocarcinoma 
cells [16]. This gene encodes a homeobox containing 
protein thought o be centrally important in the retinoic 
acid-induced ifferentiation of these ceils [17]. 
1 2 3 4 
Fig, 4. Northern analysis of 10 ~8 aliquots of mRNA showing the 
unique rcsponsivcncss of the LNCaP ceil line to DHT. Lane I I control 
androgerr withdrawn cells. Lane 2. androgen withdrawn ccltr treated 
with IO nM DHT for 12 11. Lane 3, androgcn withdrawn cclle trcatcd 
with IO aM progcztcrotic for 12 h. Lane 4, androgen withdrawn cells 
trcetcd with IO nM dcxinncthasonc for 12 It. 
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The function of this early androgen-induced gene is 
unknown at present but sequencing and expression 
studies hould allow us to examine the role of androgens 
in other androgen-sensitive systems uch as the isolated 
human sebaceous gland [IS] and hair follicle [19]. 
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